COVID-19 疫苗与肾脏疾病。
COVID-19 vaccines and kidney disease.
机构信息
Department of Internal Medicine IV, Section of Nephrology, Klinikum Wels-Grieskirchen, Wels, Austria.
Medical Faculty, Johannes Kepler University, Linz, Austria.
出版信息
Nat Rev Nephrol. 2021 May;17(5):291-293. doi: 10.1038/s41581-021-00406-6. Epub 2021 Feb 8.
Abstract
Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.
摘要
患有肾脏疾病的患者应优先接种 COVID-19 疫苗，现有数据表明，复制缺陷型病毒载体疫苗和 mRNA 疫苗的使用是安全的。由于肾脏疾病患者的疫苗反应可能低于一般人群，因此应优先选择高效疫苗。
相似文献
1
COVID-19 vaccines and kidney disease.COVID-19 疫苗与肾脏疾病。
Nat Rev Nephrol. 2021 May;17(5):291-293. doi: 10.1038/s41581-021-00406-6. Epub 2021 Feb 8.
2
Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.接受透析治疗的患者对新冠疫苗接种的抗体反应。
J Am Soc Nephrol. 2021 Oct;32(10):2435-2438. doi: 10.1681/ASN.2021050611. Epub 2021 Jun 11.
3
COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.维持性透析患者的 COVID-19 疫苗接种必要性：国际视角
Clin J Am Soc Nephrol. 2021 Nov;16(11):1746-1748. doi: 10.2215/CJN.07260521. Epub 2021 Jul 19.
4
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
5
6
SARS-CoV-2 vaccination and phase 1 cancer clinical trials.严重急性呼吸综合征冠状病毒2型疫苗接种与癌症1期临床试验。
Lancet Oncol. 2021 Mar;22(3):298-301. doi: 10.1016/S1470-2045(21)00017-6. Epub 2021 Feb 8.
7
COVID-19 vaccination: the VOICE for patients with cancer.2019冠状病毒病疫苗接种：癌症患者的心声
Nat Med. 2021 Apr;27(4):568-569. doi: 10.1038/s41591-021-01240-w.
8
Vaccine hesitancy in the COVID-19 era.新冠疫情时代的疫苗犹豫现象。
Lancet Infect Dis. 2021 Aug;21(8):1086. doi: 10.1016/S1473-3099(21)00390-X. Epub 2021 Jul 1.
9
SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy.严重急性呼吸综合征冠状病毒2型疫苗接种与实体器官移植患者：为安全性和有效性提供信息所需的数据
Transplantation. 2021 Oct 1;105(10):e131-e132. doi: 10.1097/TP.0000000000003747.
10
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.推荐的风湿性疾病患者接种 SARS-CoV-2 疫苗的模式。
J Autoimmun. 2021 Jul;121:102649. doi: 10.1016/j.jaut.2021.102649. Epub 2021 May 1.
引用本文的文献
1
Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron.奥密克戎变异株感染后血液透析患者的新型冠状病毒2型免疫纵向特征分析
Kidney Int Rep. 2024 Nov 19;10(2):406-415. doi: 10.1016/j.ekir.2024.11.012. eCollection 2025 Feb.
2
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.移植受者和血液透析患者对SARS-CoV-2疫苗的抗体反应：来自多米尼加共和国的数据。
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
3
Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎二十年
Curr Drug Targets. 2025;26(2):73-87. doi: 10.2174/0113894501323529240910015912.
4
MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with bimekizumab.在用比美吉珠单抗治疗斑块状银屑病期间接种新冠病毒疫苗后发生的髓过氧化物酶抗中性粒细胞胞浆抗体（MPO-ANCA）阳性的快速进展性肾小球肾炎
CEN Case Rep. 2025 Apr;14(2):194-199. doi: 10.1007/s13730-024-00927-6. Epub 2024 Sep 19.
5
COVID-19 infection and severe clinical outcomes in patients with kidney disease by vaccination status: a nationwide cohort study in Korea.接种疫苗状况对肾脏病患者 COVID-19 感染和严重临床结局的影响：韩国全国队列研究。
Epidemiol Health. 2024;46:e2024065. doi: 10.4178/epih.e2024065. Epub 2024 Jul 17.
6
Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan.接种 COVID-19 mRNA 疫苗后出现肉眼血尿：日本全国多中心前瞻性队列研究。
Kidney360. 2024 Sep 1;5(9):1322-1332. doi: 10.34067/KID.0000000000000498. Epub 2024 Jul 8.
7
PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patients.PMMA 透析器可调节慢性血液透析患者队列中抗 COVID-19 疫苗（BNT162b2）的体液和细胞介导免疫反应。
Sci Rep. 2024 May 28;14(1):12217. doi: 10.1038/s41598-024-62044-9.
8
Framework of Guidelines for Management of CKD in Asia.亚洲慢性肾脏病管理指南框架
Kidney Int Rep. 2023 Dec 22;9(4):752-790. doi: 10.1016/j.ekir.2023.12.010. eCollection 2024 Apr.
9
Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD.BNT162b2 和 CoronaVac 疫苗对慢性肾脏病患者中 SARS-CoV-2 奥密克戎 BA.2 的有效性。
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):418-428. doi: 10.2215/CJN.0000000000000376. Epub 2023 Dec 26.
10
Assessment of humoral immune response to different COVID-19 vaccines in patients undergoing maintenance hemodialysis.评估维持性血液透析患者对不同 COVID-19 疫苗的体液免疫反应。
J Bras Nefrol. 2023 Oct-Dec;45(4):417-423. doi: 10.1590/2175-8239-JBN-2022-0184en.
本文引用的文献
1
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.音频访谈：2020年新冠疫情的预防与护理观察
N Engl J Med. 2020 Dec 31;383(27):e147. doi: 10.1056/NEJMe2036225.
2
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility.比利时一家血液透析机构中SARS-CoV-2感染的3个月纵向血清学评估
Clin J Am Soc Nephrol. 2021 Apr 7;16(4):613-614. doi: 10.2215/CJN.12490720. Epub 2020 Nov 18.
Zotero 插件